Issue of Shares

Summary by AI BETAClose X

Aviva plc has announced the issuance of 3,664 ordinary shares on September 25, 2026, under its Global Matching Share Plan, bringing the total number of shares admitted to trading as of September 30, 2026, to 3,001,454,347. These newly issued shares, with a nominal value of 32 17/19 pence each, are fully fungible with existing ordinary shares and were previously admitted to the London Stock Exchange's Main Market.

Disclaimer*

Aviva PLC
01 October 2026
 

 

 

 

 

01 October 2026

Aviva plc

Issue of Shares

 

In accordance with the Financial Conduct Authority’s Prospectus Regime Manual Rule 1.6.4R, Aviva plc (the Company) announces that between 1 September 2026 and 30 September 2026 it has issued and allotted 3,664 ordinary shares of 32 17/19 pence each (ISIN: GB00BPQY8M80) in connection with Company employee share schemes, as detailed below.

The shares were previously admitted to trading on the London Stock Exchange Main Market under a block admission to trading.

The shares rank equally and are fully fungible with the existing ordinary shares of the Company.

Number of further shares admitted to trading covered by the notification:

3,664 shares issued on 25 September 2026 – Global Matching Share Plan

 

 

Total number of shares admitted to trading as at 30 September 2026 (taking into account the further issuance):

3,001,454,347

 

 

-ends-

 

LEI: YF0Y5B0IB8SM0ZFG9G81

 

Enquiries:

 

Media:

 

Andrew Reid

+44 (0)7800 694 276

Sarah Swailes

Alice Constable

+44 (0)7800 694 859

+44 (0)7350 398 942

 

 

Analysts:

 

Michael O'Hara

Joel von Sternberg

+44 (0)7387 234 388

+44 (0)7384 231 238

Giles White

+44 (0)7385 011 249

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Aviva (AV.)
UK 100

Latest directors dealings